Shares of Select Medical Holdings Co. (NYSE:SEM) have earned a consensus rating of “Buy” from the eleven research firms that are covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price target among analysts that have covered the stock in the last year is $20.57.
Several research firms have weighed in on SEM. Zacks Investment Research upgraded shares of Select Medical from a “sell” rating to a “hold” rating in a research note on Friday, June 8th. ValuEngine lowered shares of Select Medical from a “strong-buy” rating to a “buy” rating in a research note on Monday, May 7th. TheStreet upgraded shares of Select Medical from a “c+” rating to a “b-” rating in a research note on Thursday, March 1st. JMP Securities upgraded shares of Select Medical from an “underperform” rating to a “market perform” rating and set a $12.00 price objective on the stock in a research note on Tuesday, February 27th. Finally, Robert W. Baird reiterated a “buy” rating and issued a $26.00 price objective on shares of Select Medical in a research note on Friday, February 23rd.
In other Select Medical news, VP Robert G. Breighner, Jr. sold 3,428 shares of the company’s stock in a transaction that occurred on Tuesday, May 8th. The shares were sold at an average price of $18.03, for a total value of $61,806.84. Following the transaction, the vice president now owns 31,589 shares in the company, valued at approximately $569,549.67. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Chairman Robert A. Ortenzio sold 46,611 shares of the stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $18.52, for a total transaction of $863,235.72. Following the transaction, the chairman now owns 7,225,885 shares in the company, valued at approximately $133,823,390.20. The disclosure for this sale can be found here. In the last quarter, insiders sold 640,931 shares of company stock worth $11,901,380. Company insiders own 19.86% of the company’s stock.
Shares of SEM stock traded up $0.05 during trading hours on Thursday, reaching $18.50. 424,779 shares of the stock traded hands, compared to its average volume of 614,840. Select Medical has a 1-year low of $13.90 and a 1-year high of $19.77. The company has a debt-to-equity ratio of 3.60, a current ratio of 1.66 and a quick ratio of 1.66. The firm has a market capitalization of $2.51 billion, a P/E ratio of 19.07, a P/E/G ratio of 1.27 and a beta of 1.31.
Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, May 3rd. The health services provider reported $0.29 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.26 by $0.03. Select Medical had a net margin of 4.23% and a return on equity of 15.19%. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter in the previous year, the business earned $0.21 earnings per share. The firm’s revenue was up 14.7% compared to the same quarter last year. sell-side analysts predict that Select Medical will post 1.05 EPS for the current fiscal year.
About Select Medical
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.